For most women at average risk, a mammogram every two years starting at age 40 is the current standard. That recommendation, updated in 2024 by the U.S. Preventive Services Task Force (USPSTF), shifted the starting age down from 50 to 40 and applies through age 74. But the schedule isn’t one-size-fits-all. Your age, breast density, and family history can all change how often you should be screened.
The Standard Schedule for Average-Risk Women
The USPSTF now recommends biennial (every two years) screening mammography for all women aged 40 to 74. This is a Grade B recommendation, meaning there’s strong evidence that the benefits outweigh the harms. The task force specifically noted that biennial screening has a more favorable trade-off of benefits versus harms compared to annual screening, largely because it reduces false positives and unnecessary follow-up procedures while still catching cancers early.
Under the Affordable Care Act, any preventive service with an A or B grade from the USPSTF must be covered by insurance with no cost-sharing. That means most health plans cover a screening mammogram every two years starting at 40 with no copay or deductible.
How ACS Guidelines Differ by Age
The American Cancer Society takes a slightly different, more age-specific approach. Their breakdown:
- Ages 40 to 44: Screening is optional. You can choose to start yearly mammograms if you want.
- Ages 45 to 54: Yearly mammograms are recommended.
- Ages 55 and older: You can switch to every other year, or continue yearly screening if you prefer.
The ACS recommends continuing screening as long as you’re in good health and expected to live at least 10 more years. There’s no hard cutoff age the way the USPSTF draws a line at 74. This means a healthy 78-year-old might still benefit from regular screening, while someone with serious health conditions at 70 might reasonably stop.
The practical difference between these two sets of guidelines comes down to how aggressively you screen in your 40s and early 50s. If you follow the USPSTF, you’d get roughly 17 mammograms between ages 40 and 74. Under the ACS guidelines with yearly screening from 45 to 54, the total is notably higher. Neither approach is wrong. They reflect different judgments about the balance between catching cancer early and the downsides of more frequent screening.
Why Annual Screening Has Trade-Offs
More screening sounds better in theory, but it comes with a real cost: false positives. Over 10 years of annual mammograms, a 60-year-old woman has roughly a 47% chance of getting at least one false-positive result that leads to follow-up testing, and about a 19% chance of a false positive that leads to a biopsy. These aren’t dangerous, but they create anxiety, additional appointments, and sometimes invasive procedures for something that turns out to be nothing.
Biennial screening cuts those numbers significantly while still detecting the large majority of cancers at a treatable stage. That’s the core reason the USPSTF favors every-two-year screening for average-risk women.
When You May Need Yearly Screening
Some women benefit from more frequent mammograms regardless of what the general guidelines say. Annual screening is typically recommended if you have a family history of breast or ovarian cancer, a personal history of ovarian cancer, a known genetic mutation that raises breast cancer risk, or a history of chest radiation before age 30.
Research from the Ontario Breast Screening Program found that annual screening improved cancer detection for women with a family or personal history of breast or ovarian cancer compared to biennial screening. Sensitivity (the ability to correctly identify cancer) jumped from about 71% with biennial screening to nearly 82% with annual screening, with the biggest gains for invasive cancers and postmenopausal women. Annual screening in this group also resulted in fewer interval cancers, which are tumors that appear between scheduled screenings and tend to have worse outcomes.
The trade-off was a slightly higher rate of false positives, particularly among premenopausal women whose breast tissue is naturally denser. But for women with elevated risk, catching cancer earlier generally outweighs the inconvenience of occasional false alarms.
Dense Breast Tissue Changes the Equation
About half of women have dense breasts, and density matters for two reasons: it makes cancers harder to spot on a standard mammogram, and it independently raises breast cancer risk. Women with extremely dense breast tissue are underserved by mammography alone, even high-quality digital mammography.
For women with the highest density category, supplemental imaging can fill the gap. The European Society of Breast Imaging recommends that women aged 50 to 70 with extremely dense breasts receive a breast MRI every two to four years in addition to (or instead of) standard mammography. Some countries have already integrated supplemental ultrasound into screening programs for women with dense breasts.
If you’ve been told you have dense breasts on a prior mammogram report, it’s worth discussing supplemental screening options. As of 2024, federal law requires mammography facilities to notify you about your breast density, so this information should appear in your results letter. The notification doesn’t automatically change your screening schedule, but it gives you the information to have that conversation.
What About 3D Mammography?
Digital breast tomosynthesis, commonly called 3D mammography, creates layered images of the breast and is increasingly used in place of traditional 2D mammograms. It’s better at finding cancers in dense tissue and produces fewer false positives. However, current research hasn’t established that 3D mammography allows you to safely extend the time between screenings. Most of the data on screening intervals comes from programs using standard 2D mammography, so the recommended frequency stays the same whether you get a 2D or 3D mammogram.
A Practical Way to Think About Your Schedule
If you’re 40 or older with no major risk factors, every two years is a well-supported starting point. If you have a strong family history, a known genetic risk, or extremely dense breasts, annual screening (possibly with supplemental imaging) is likely the better choice. Between 45 and 54, annual screening aligns with ACS guidance and is reasonable even for average-risk women who want more frequent monitoring.
The most important thing isn’t which exact schedule you follow. It’s that you have a schedule at all. Women who skip screening entirely face far worse outcomes than women who debate the merits of annual versus biennial. Pick a cadence that fits your risk level, set a recurring reminder, and stick with it.